Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1994 May 1;179(5):1467–1473. doi: 10.1084/jem.179.5.1467

Borna disease virus-specific T cells protect against or cause immunopathological Borna disease

PMCID: PMC2191504  PMID: 7909324

Abstract

In this report we show that passive immunization of Lewis rats with viable CD4+, Borna disease virus (BDV)-specific T cells before infection with BDV resulted in protection against BD, whereas inoculation of these T cells after BDV infection induced clinical disease with more rapid onset than seen in BDV control animals. The protective as well as encephalitogenic effector functions of BDV- specific CD4+ T cells were mediated only by viable BDV-specific T cells. The protective situation was obtained by passive transfer of BDV- specific T cells into animals inoculated later with virus, whereas the immunopathological situation was observed when virus-specific T cells developed normally or after adoptive transfer, and appeared on the scene after considerable virus replication in the brain.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briese T., de la Torre J. C., Lewis A., Ludwig H., Lipkin W. I. Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11486–11489. doi: 10.1073/pnas.89.23.11486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Haas B., Becht H., Rott R. Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J Gen Virol. 1986 Feb;67(Pt 2):235–241. doi: 10.1099/0022-1317-67-2-235. [DOI] [PubMed] [Google Scholar]
  4. Herzog S., Frese K., Rott R. Studies on the genetic control of resistance of black hooded rats to Borna disease. J Gen Virol. 1991 Mar;72(Pt 3):535–540. doi: 10.1099/0022-1317-72-3-535. [DOI] [PubMed] [Google Scholar]
  5. Herzog S., Kompter C., Frese K., Rott R. Replication of Borna disease virus in rats: age-dependent differences in tissue distribution. Med Microbiol Immunol. 1984;173(4):171–177. doi: 10.1007/BF02122108. [DOI] [PubMed] [Google Scholar]
  6. Herzog S., Rott R. Replication of Borna disease virus in cell cultures. Med Microbiol Immunol. 1980;168(3):153–158. doi: 10.1007/BF02122849. [DOI] [PubMed] [Google Scholar]
  7. Herzog S., Wonigeit K., Frese K., Hedrich H. J., Rott R. Effect of Borna disease virus infection on athymic rats. J Gen Virol. 1985 Mar;66(Pt 3):503–508. doi: 10.1099/0022-1317-66-3-503. [DOI] [PubMed] [Google Scholar]
  8. Howell M. D., Winters S. T., Olee T., Powell H. C., Carlo D. J., Brostoff S. W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science. 1989 Nov 3;246(4930):668–670. doi: 10.1126/science.2814489. [DOI] [PubMed] [Google Scholar]
  9. Ludwig H., Bode L., Gosztonyi G. Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol. 1988;35:107–151. [PubMed] [Google Scholar]
  10. Narayan O., Herzog S., Frese K., Scheefers H., Rott R. Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science. 1983 Jun 24;220(4604):1401–1403. doi: 10.1126/science.6602380. [DOI] [PubMed] [Google Scholar]
  11. Planz O., Bilzer T., Sobbe M., Stitz L. Lysis of major histocompatibility complex class I-bearing cells in Borna disease virus-induced degenerative encephalopathy. J Exp Med. 1993 Jul 1;178(1):163–174. doi: 10.1084/jem.178.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Richt J. A., Clements J. E., Herzog S., Pyper J., Wahn K., Becht H. Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus. Med Microbiol Immunol. 1993 Nov;182(5):271–280. doi: 10.1007/BF00579625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Richt J. A., Herzog S., Haberzettl K., Rott R. Demonstration of Borna disease virus-specific RNA in secretions of naturally infected horses by the polymerase chain reaction. Med Microbiol Immunol. 1993 Dec;182(6):293–304. doi: 10.1007/BF00191945. [DOI] [PubMed] [Google Scholar]
  14. Richt J. A., Stitz L. Borna disease virus-infected astrocytes function in vitro as antigen-presenting and target cells for virus-specific CD4-bearing lymphocytes. Arch Virol. 1992;124(1-2):95–109. doi: 10.1007/BF01314628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Richt J. A., Stitz L., Wekerle H., Rott R. Borna disease, a progressive meningoencephalomyelitis as a model for CD4+ T cell-mediated immunopathology in the brain. J Exp Med. 1989 Sep 1;170(3):1045–1050. doi: 10.1084/jem.170.3.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Richt J. A., VandeWoude S., Zink M. C., Clements J. E., Herzog S., Stitz L., Rott R., Narayan O. Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis. 1992 Jun;14(6):1240–1250. doi: 10.1093/clinids/14.6.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richt J., Stitz L., Deschl U., Frese K., Rott R. Borna disease virus-induced meningoencephalomyelitis caused by a virus-specific CD4+ T cell-mediated immune reaction. J Gen Virol. 1990 Nov;71(Pt 11):2565–2573. doi: 10.1099/0022-1317-71-11-2565. [DOI] [PubMed] [Google Scholar]
  18. Rott R., Herzog S., Bechter K., Frese K. Borna disease, a possible hazard for man? Arch Virol. 1991;118(3-4):143–149. doi: 10.1007/BF01314025. [DOI] [PubMed] [Google Scholar]
  19. Shankar V., Kao M., Hamir A. N., Sheng H., Koprowski H., Dietzschold B. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol. 1992 Feb;66(2):992–998. doi: 10.1128/jvi.66.2.992-998.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Steinman L. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol. 1991;49:357–379. doi: 10.1016/s0065-2776(08)60779-8. [DOI] [PubMed] [Google Scholar]
  21. Stitz L., Soeder D., Deschl U., Frese K., Rott R. Inhibition of immune-mediated meningoencephalitis in persistently Borna disease virus-infected rats by cyclosporine A. J Immunol. 1989 Dec 15;143(12):4250–4256. [PubMed] [Google Scholar]
  22. Thiedemann N., Presek P., Rott R., Stitz L. Antigenic relationship and further characterization of two major Borna disease virus-specific proteins. J Gen Virol. 1992 May;73(Pt 5):1057–1064. doi: 10.1099/0022-1317-73-5-1057. [DOI] [PubMed] [Google Scholar]
  23. Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 1989 Oct 12;341(6242):541–544. doi: 10.1038/341541a0. [DOI] [PubMed] [Google Scholar]
  24. Zheng Y. M., Schäfer M. K., Weihe E., Sheng H., Corisdeo S., Fu Z. F., Koprowski H., Dietzschold B. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Virol. 1993 Oct;67(10):5786–5791. doi: 10.1128/jvi.67.10.5786-5791.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES